Federal Reserve kept rates steady on Wednesday, and maintained forecasts for three rate-cuts this year, pointing to the central bank’s confidence that the recent strength in inflation is unlikely to derail the progress made so far
Related Posts

ZOMATO Zepto has started charging Rs 2/order platform fee in certain markets for select users
- Raj Gaurav Rai
- March 15, 2024
ZOMATO Zepto has started charging Rs 2/order platform fee in certain markets for select users Please follow and like us:
FITCH: INDIA’S RATING IS UNDERPINNED BY A ROBUST MEDIUM-TERM GDP GROWTH OUTLOOK AND SOUND EXTERNAL FINANCES FITCH: INDIA IS POISED TO REMAIN ONE OF FASTEST-GROWING COUNTRIES GLOBALLY IN NEXT FEW YEARS FITCH ON INDIA SAYS BEYOND FY24 THERE IS LESS CERTAINTY ON FISCAL PATH AND TRADE-OFFS BETWEEN ECONOMIC GROWTH AND CONSOLIDATION MAY BECOME MORE ACUTE
- Raj Gaurav Rai
- January 16, 2024
FITCH: INDIA'S RATING IS UNDERPINNED BY A ROBUST MEDIUM-TERM GDP GROWTH OUTLOOK AND SOUND EXTERNAL FINANCES FITCH: INDIA IS POISED TO REMAIN ONE OF FASTEST-GROWING […]
ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading  ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading
- Raj Gaurav Rai
- August 1, 2024
ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading  ydus has received marketing approval from Mexican regulatory […]